This chip delivers Covid-19 test results on your phone

Novel chip for Covid-19 testing delivers results on smartphone

The microfluidic chip is developed by researchers from Rice University in the US

Credit: AFP Photo

Scientists have developed a stamp-sized chip that simplifies Covid-19 testing, and delivers results on a smartphone in less than 55 minutes.

The microfluidic chip developed by researchers from Rice University in the US measures the concentration of SARS-CoV-2 nucleocapsid (N) protein, a biomarker for Covid-19, in blood serum from a standard finger prick.

According to the research published in the journal ACS Sensors, the nanobeads bind to SARS-CoV-2 N protein in the chip and transport it to an electrochemical sensor that detects minute amounts of the biomarker.

The researchers noted that their process simplifies sample handling compared to swab-based PCR tests that are widely used to diagnose Covid-19 and need to be analysed in a laboratory.

"What's great about this device is that it doesn't require a laboratory," said Rice lab of mechanical engineer Peter Lillehoj.

"You can perform the entire test and generate the results at the collection site, health clinic or even a pharmacy. The entire system is easily transportable and easy to use," he said in a statement.

Read | India beats China at its own game in vaccine diplomacy battle

The team, including Rice graduate student and lead author Jiran Li, took advantage of existing biosensing tools to develop simple diagnostics, like a microneedle patch introduced last year to diagnose malaria.

The new tool relies on a slightly more complex detection scheme but delivers accurate, quantitative results in a short amount of time.

To test the device, the resaerchers relied on donated serum samples from people who were healthy and others who were Covid-19-positive.

They said a longer incubation yields more accurate results when using the whole serum.

The team found that 55 minutes was an optimum amount of time for the microchip to sense SARS-CoV-2 N protein at concentrations as low as 50 picograms (billionths of a gram) per millilitre in whole serum.

The microchip could detect N protein in even lower concentrations, at 10 picograms per milliliter, in only 25 minutes by diluting the serum fivefold.

Paired with a Google Pixel 2 phone and a plug-in potentiostat -- a device that controls voltage and measures resulting current -- it was able to deliver a positive diagnosis with a concentration as low as 230 picograms for whole serum.

"There are standard procedures to modify the beads with an antibody that targets a particular biomarker," Lillehoj said.

"When you combine them with a sample containing the biomarker, in this case, SARS-CoV-2 N protein, they bond together," he added.

A capillary tube is used to deliver the sample to the chip, which is then placed on a magnet that pulls the beads towards an electrochemical sensor coated with capture antibodies.

The beads bind to the capture antibodies and generate a current proportional to the concentration of the biomarker in the sample.

The potentiostat reads that current and sends a signal to its phone app.

If there are no Covid-19 biomarkers, the beads do not bind to the sensor and get washed away inside the chip. 

Get a round-up of the day's top stories in your inbox

Check out all newsletters

Get a round-up of the day's top stories in your inbox